Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta‐analysis

Vancampfort, Davy, Stubbs, Brendon, Mitchell, Alex J., De Hert, Marc, Wampers, Martien, Ward, Philip B., Rosenbaum, Simon, Correll, Christoph U.·2015·World Psychiatry

Cited by (1,000)

Items 101–200 of 1,000

  1. Access to primary and specialized somatic health care for persons with severe mental illness: a qualitative study of perceived barriers and facilitators in Swedish health care
    Elisabeth Björk Brämberg, Jarl Torgerson, Anna Norman Kjellström, Peder Welin, Marie Rusner · 2018 · BMC Family Practice
  2. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study
    Marco Solmi, Jari Tiihonen, Markku Lähteenvuo, Antti J. Tanskanen, Christoph Ulrich Correll, Heidi T. Taipale · 2021 · Schizophrenia Bulletin
  3. Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia
    Zachary Freyberg, Despoina Aslanoglou, Ripal N. Shah, Jacob S. Ballon · 2017 · Frontiers in Neuroscience
  4. Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies
    Kyle Jon Burghardt, Berhane Seyoum, Abdullah Mallisho, Paul Ryen Burghardt, Renu A. Kowluru, Zhengping Yi · 2018 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  5. Barriers and facilitators to health care providers’ promotion of physical activity for individuals with mental illness: A scoping review
    Krista Glowacki, Katie A. Weatherson, Guy Faulkner · 2018 · Mental health and physical activity
  6. Increasing mortality gap for patients diagnosed with bipolar disorder—A nationwide study with 20 years of follow‐up
    Pernille Staudt Hansen, Mathilde Frahm Laursen, Simon Grøntved, Sune Puggaard Vogt Straszek, Rasmus Wentzer Licht, René Ernst Nielsen · 2018 · Bipolar Disorders
  7. Acute bouts of exercising improved mood, rumination and social interaction in inpatients with mental disorders
    Brand, Serge, Colledge, Flora, Ludyga, Sebastian, Emmenegger, Raphael, Kalak, Nadeem, Sadeghi Bahmani, Dena, Holsboer-Trachsler, Edith, Pühse, Uwe, Gerber, Markus · 2018 · Frontiers in Psychology
  8. Increased mortality from somatic multimorbidity in patients with schizophrenia: a Danish nationwide cohort study
    Pirathiv Kugathasan, Brendon Stubbs, Jørgen Aagaard, Svend Eggert Jensen, Thomas Munk Laursen, René Ernst Nielsen · 2019 · Acta Psychiatrica Scandinavica
  9. Cardiovascular effects of psychotic illnesses and antipsychotic therapy
    Sandra Howell, Ekaterina Yarovova, Ahmad Khwanda, Stuart David Rosen · 2019 · Heart
  10. Disparities in COVID-19 infection, hospitalisation and death in people with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of the UK Biobank
    Lamiece Hassan, Niels B. Peek, Karina Lovell, Andre Ferrer Carvalho, Marco Solmi, Brendon Stubbs, Joseph Firth · 2021 · Molecular Psychiatry
  11. Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia
    Christoph Ulrich Correll, Angel S. Angelov, Andrew Miller, Peter J. Weiden, Stephen K. Brannan · 2022 · Schizophrenia
  12. Consensus statement on the role of Accredited Exercise Physiologists within the treatment of mental disorders: a guide for mental health professionals
    O. Lederman, Kristine Grainger, R. Stanton, Angela Douglas, K. Gould, A. Perram, Rishi Baldeo, Theodora Fokas, Fiona Nauman, Amanda Semaan et al. · 2016 · Australasian Psychiatry
  13. Physical Activity Levels and Psychosis: A Mediation Analysis of Factors Influencing Physical Activity Target Achievement Among 204 186 People Across 46 Low- and Middle-Income Countries
    Brendon Stubbs, Ai Koyanagi, Felipe Barreto Schuch, Joseph Firth, Simon Rosenbaum, Fiona Gaughran, James Mugisha, Davy Vancampfort · 2016 · Schizophrenia Bulletin
  14. Trends in utilization and dosing of antipsychotic drugs in Scandinavia: Comparison of 2006 and 2016
    Mikkel Højlund, Anton Pottegård, Erik Johnsen, Rune A. Kroken, Johan Reutfors, Povl Munk‐Jørgensen, Christoph Ulrich Correll · 2019 · British Journal of Clinical Pharmacology
  15. Posttraumatic Stress Disorder-Related Cardiovascular Disease and Accelerated Cellular Aging
    Erika J. Wolf, Paula P. Schnurr · 2016 · Psychiatric Annals
  16. Improving life expectancy in people with serious mental illness: Should we place more emphasis on primary prevention?
    Athif Ilyas, Edward Chesney, Rashmi Patel · 2017 · The British Journal of Psychiatry
  17. The relationship between the dietary inflammatory index (DII®) and incident depressive symptoms: A longitudinal cohort study
    Nitin Shivappa, James R. Hébert, Nicola Veronese, Maria Gabriella Caruso, Maria Notarnicola, Stefania Maggi, Brendon Stubbs, Joseph Firth, Michele Fornaro, Marco Solmi · 2018 · Journal of Affective Disorders
  18. Depression and metabolic syndrome in the older population: A review of evidence
    Nikolena Repousi, María F. Masana, Albert Sanchez Niubo, Josep Maria Haro, Stefanos Tyrovolas · 2018 · Journal of Affective Disorders
  19. The Place of Social Recovery in Mental Health and Related Services
    Shulamit Ramon · 2018 · International Journal of Environmental Research and Public Health
  20. Improving physical health of patients with severe mental disorders: a critical review of lifestyle psychosocial interventions
    Corrado De Rosa, Gaia Sampogna, Mario Luciano, Valeria Del Vecchio, Benedetta Pocai, Giuseppina Borriello, Vincenzo Giallonardo, Micaela Savorani, Federica Pinna, Maurizio Pompili et al. · 2017 · Expert Review of Neurotherapeutics
  21. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha
    Chen Zhang, Xinyu Fang, Peifen Yao, Yemeng Mao, Jun Cai, Yi Zhang, Meijuan Chen, Weixing Fan, Wei Tang, Lisheng Song · 2017 · Psychoneuroendocrinology
  22. The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: an umbrella review of the evidence from randomised controlled trials
    Croatto, Giovanni, Vancampfort, Davy, Miola, Alessandro, Olivola, Miriam, Fiedorowicz, Jess G., Firth, Joseph, Alexinschi, Ovidiu, Gaina, Marcel A., Makkai, Vladimir, Soares, Fernanda Cunha et al. · 2023 · Molecular Psychiatry
  23. One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients
    Svensson, C. K., Larsen, J. R., Vedtofte, L., Jakobsen, M. S. L., Jespersen, H. R., Jakobsen, M. I., Koyuncu, K., Schjerning, O., Nielsen, J., Ekstrøm, C. T. et al. · 2019 · Acta Psychiatrica Scandinavica
  24. Psychiatric and physical comorbidities and their impact on the course of bipolar disorder: A prospective, naturalistic 4‐year follow‐up study
    Benedikt Lorenz Amann, Joaquim Raduà, Christian Wunsch, Barbara König, Christian Simhandl · 2017 · Bipolar Disorders
  25. Antipsychotic treatment – a systematic literature review and meta-analysis of qualitative studies
    Jone Ravndal Bjørnestad, Kristina Osland Lavik, Larry Davidson, Aslak Hjeltnes, Christian Moltu, Marius Veseth · 2019 · Journal of Mental Health
  26. Did the Brain and Oral Microbiota Talk to Each Other? A Review of the Literature
    Yoann Maitre, Pierre Micheneau, Alexis Delpierre, Rachid Mahalli, Marie Guérin, Gilles Amador, Frédéric Denis · 2020 · Journal of Clinical Medicine
  27. Semaglutide Treatment of Antipsychotic-Treated Patients With Schizophrenia, Prediabetes, and Obesity
    Ashok Ainkaran Ganeshalingam, Nicolai Gundtoft Uhrenholt, Sidse Arnfred, Peter Gæde, Signe Wegmann Düring, Elsebeth Nylev Stenager, Nick Bünger, Andreas Kristian Pedersen, Niels Bilenberg, Jan Frystyk · 2025 · JAMA Psychiatry
  28. Physical activity and quality of life in long-term hospitalized patients with severe mental illness: a cross-sectional study
    Jeroen Deenik, Frank R Kruisdijk, Diederik E. Tenback, Annemarie Braakman‐Jansen, Erik Taal, M. Hopman-Rock, Aartjan T.F. Beekman, Erwin C. P. M. Tak, Ingrid J.M. Hendriksen, Peter N. van Harten · 2017 · BMC Psychiatry
  29. Cognitive behavior therapy combined with exercise for adults with chronic diseases: Systematic review and meta-analysis.
    Paquito Bernard, Ahmed Jérôme Romain, Johan Caudroit, Guillaume Chevance, Marion Carayol, Mathieu Gourlan, Kelsey Needham Dancause, Grégory Moullec · 2018 · Health Psychology
  30. Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives
    Klara Coello, Maj Vinberg, Filip Krag Knop, Bente Klarlund Pedersen, Roger S. McIntyre, Lars Vedel Kessing, Klaus Munkholm · 2019 · International Journal of Bipolar Disorders
  31. Neurobiological effects of aerobic exercise, with a focus on patients with schizophrenia
    Isabel Maurus, Alkomiet Hasan, Astrid Röh, Shun Takahashi, Boris‐Stephan Rauchmann, Daniel Keeser, Berend Malchow, Andrea Schmitt, Peter Falkai · 2019 · European Archives of Psychiatry and Clinical Neuroscience
  32. Facebook for Supporting a Lifestyle Intervention for People with Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: an Exploratory Study
    Naslund, John A., Aschbrenner, Kelly A., Marsch, Lisa A., McHugo, Gregory J., Bartels, Stephen J. · 2018 · Psychiatric Quarterly
  33. Interleukin-6 and depressive symptom severity in response to physical exercise
    Catharina Lavebratt, Matthew Payton Herring, Jia Jia Liu, Ya Bin Wei, Davide Bossoli, Mats Å. Hallgren, Yvonne Forsell · 2017 · Psychiatry Research
  34. Short Term Intrarectal Administration of Sodium Propionate Induces Antidepressant-Like Effects in Rats Exposed to Chronic Unpredictable Mild Stress
    Jianguo Li, Luwen Hou, Cui Wang, Xueyang Jia, Xuemei Qin, Changxin Wu · 2018 · Frontiers in Psychiatry
  35. Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
    Gary S. Sachs, Paul P. Yeung, Ludmyla Rekeda, Arifulla Khan, Julie Adams, Maurizio Fava M. D · 2023 · American Journal of Psychiatry
  36. The evidence for physical activity in the management of major mental illnesses
    Garcia Ashdown‐Franks, Catherine Michelle Sabiston, Brendon Stubbs · 2019 · Current Opinion in Psychiatry
  37. Brain-immune crosstalk in the treatment of major depressive disorder
    Igor Branchi, Silvia Poggini, Lucile Capuron, Francesco Benedetti, Sara Poletti, Ryad Tamouza, Hemmo A. Drexhage, Brenda W.J.H. Penninx, Carmine Maria Pariante · 2020 · European Neuropsychopharmacology
  38. Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls
    Shuichi Suetani, Faraz Honarparvar, Dan J. Siskind, Guy Hindley, Nicola Veronese, Davy Vancampfort, Lauren Allen, Marco Solmi, John Lally, Fiona Gaughran et al. · 2021 · Schizophrenia Research
  39. Impact of obesity and mood disorders on physical comorbidities, psychological well-being, health behaviours and use of health services
    Ahmed Jérôme Romain, Jacques D. Marleau, Aurélie Baillot · 2017 · Journal of Affective Disorders
  40. An umbrella review of adverse effects associated with antipsychotic medications: the need for complementary study designs
    Rachel T.S. Chow, Daniel Whiting, Louis Favril, Edoardo Giuseppe Ostinelli, Andrea Cipriani, Seena Fazel · 2023 · Neuroscience & Biobehavioral Reviews
  41. Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder
    Grootens, Koen P., Meijer, Anna, Hartong, Erwin G., Doornbos, Bennard, Bakker, P. Roberto, Al Hadithy, Asmar, Hoogerheide, Kirsten N., Overmeire, Frans, Marijnissen, Radboud M., Ruhe, Henricus G. · 2018 · European Journal of Clinical Pharmacology
  42. Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations
    Nicolette Stogios, Bailey E. Humber, Sri Mahavir Agarwal, Margaret Hahn · 2023 · Current Psychiatry Reports
  43. Changes in physical and psychiatric health after a multidisciplinary lifestyle enhancing treatment for inpatients with severe mental illness: The MULTI study I
    Jeroen Deenik, Diederik E. Tenback, Erwin C. P. M. Tak, Femke Rutters, Ingrid J.M. Hendriksen, Peter N. van Harten · 2018 · Schizophrenia Research
  44. Obesity as a Risk Factor for Accelerated Brain Ageing in First-Episode Psychosis—A Longitudinal Study
    Sean R. McWhinney, Marián Kolenič, Katja Franke, Markéta Fialová, Pavel Knytl, Martin Matějka, Filip Španiel, Tomáš Hájek · 2021 · Schizophrenia Bulletin
  45. Metabolic syndrome in antipsychotic-naïve patients with first-episode psychosis: a systematic review and meta-analysis
    Nathalia Garrido Torres, Idalino Rocha-González, Luis Alameda, Aurora Rodriguez Gangoso, Ana Vilches, Manuel Canal‐Rivero, Benedicto Crespo‐Facorro, Miguel Ruíz-Veguilla · 2021 · Psychological Medicine
  46. Depression and Metabolic Syndrome: A Narrative Review
    Yousef Al-Khatib, Muhammad Adeel Akhtar, M. Ali Kanawati, Rumbidzai Mucheke, Maria Mahfouz, Maysan Al-Nufoury · 2022 · Cureus
  47. Depressive symptoms, handgrip strength, and weight status in US older adults
    Lee Smith, Stephanie Stockwell, Brendon Stubbs, Liang Hu, Nicola Veronese, Davy Vancampfort, Mark Hamer, Benjamin Gardner, Lin Yang · 2018 · Journal of Affective Disorders
  48. Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin
    Rodrigo Barbachan Mansur, Francheska Delgado‐Peraza, Mehala Subramaniapillai, Yena L. Lee, Michelle Iacobucci, Flora Nasri, Nelson B. Rodrigues, Joshua Daniel Rosenblat, Elisa Macedo Brietzke, Victoria E. Cosgrove et al. · 2020 · Journal of Psychiatric Research
  49. Obesity and brain structure in schizophrenia – ENIGMA study in 3021 individuals
    Sean R. McWhinney, Katharina Brosch, Vince D. Calhoun, Benedicto Crespo‐Facorro, Nicolas Andres Crossley, Udo Dannlowski, Erin W. Dickie, Lorielle M. F. Dietze, Gary J Donohoe, Stefan S. du Plessis et al. · 2022 · Molecular Psychiatry
  50. Use of low‐dose quetiapine increases the risk of major adverse cardiovascular events: results from a nationwide active comparator‐controlled cohort study
    Mikkel Højlund, Kjeld Andersen, Martin T. Ernst, Christoph Ulrich Correll, Jesper Hallas · 2022 · World Psychiatry
  51. Does physical activity reduce the risk of psychosis? A systematic review and meta-analysis of prospective studies
    Brokmeier, Luisa Leonie, Firth, Joseph, Vancampfort, Davy, Smith, Lee, Deenik, Jeroen, Rosenbaum, Simon, Stubbs, Brendon, Schuch, Felipe Barreto · 2020 · Psychiatry Research
  52. The promise of zebrafish as a model of metabolic syndrome
    Khaled Benchoula, Alfi Khatib, Ashika Jaffar, Qamar Uddin Ahmed, Wan Mohd Azizi Wan Sulaiman, Ridhwan Abdul Wahab, Hesham Rushdey El-Seedi · 2019 · EXPERIMENTAL ANIMALS
  53. Gut microbiota-derived short chain fatty acids act as mediators of the gut-liver-brain axis
    Cheng Li, Jingtong Yao, Chang‐Hao Yang, Shengnan Yu, Zizhen Yang, Lijing Wang, Shangyong Li, Ningning He · 2025 · Metabolic Brain Disease
  54. Peer support interventions seeking to improve physical health and lifestyle behaviours among people with serious mental illness: A systematic review
    Brendon Stubbs, Julie Williams, Jennifer Shannon, Fiona Gaughran, Tom Craig · 2016 · International Journal of Mental Health Nursing
  55. Trace elements in schizophrenia: a systematic review and meta-analysis of 39 studies (N = 5151 participants)
    Amene Saghazadeh, Maryam Mahmoudi, Shayan Shahrokhi, Maryam Mojarrad, Maedeh Dastmardi, Mona Mirbeyk, Nima Rezaei · 2019 · Nutrition Reviews
  56. Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: a systematic review and meta-analysis
    Li, Lin, Yao, Honghui, Zhang, Le, Garcia‐Argibay, Miguel, Du Rietz, Ebba, Brikell, Isabell, Solmi, Marco, Cortese, Samuele, Ramos‐Quiroga, J. Antoni, Ribasés, Marta et al. · 2023 · JCPP Advances
  57. Clinical correlates of vitamin D deficiency in established psychosis
    John Lally, Poonam Gardner-Sood, Mudasir Firdosi, Conrad Osamede Iyegbe, Brendon Stubbs, Kathryn Greenwood, Robin M. Murray, Shubulade M Smith, Oliver David Howes, Fiona Gaughran · 2016 · BMC Psychiatry
  58. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha
    Liying Ren, Dongmei Sun, Xia Zhou, Yifan Yang, Xiaoqian Huang, Yangxue Li, Chunxia Wang, Yuhao Li · 2018 · Journal of Ethnopharmacology
  59. Effectiveness of yoga for major depressive disorder: A systematic review and meta-analysis
    Wu, Yufei, Yan, Danni, Yang, Jianli · 2023 · Frontiers in Psychiatry
  60. Physical activity ameliorates the association between sedentary behavior and cardiometabolic risk among inpatients with schizophrenia: A comparison versus controls using accelerometry
    Brendon Stubbs, Li‐Jung Chen, Ming-Shun Chung, Po‐Wen Ku · 2017 · Comprehensive Psychiatry
  61. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study
    Yi Zhang, Xinyu Fang, Weixing Fan, Wei Tang, Jun Cai, Lisheng Song, Chen Zhang · 2018 · Psychopharmacology
  62. Association between body mass index and subcortical brain volumes in bipolar disorders–ENIGMA study in 2735 individuals
    Sean R. McWhinney, C. Abé, M. Alda, F. Benedetti, E. Bøen, C. Del Mar Bonnin, T. Borgers, K. Brosch, E. Canales-Rodríguez, D. Cannon et al. · 2021 · Molecular Psychiatry
  63. Accelerometer-measured sedentary behaviour and physical activity of inpatients with severe mental illness
    Frank R Kruisdijk, Jeroen Deenik, Diederik E. Tenback, Erwin C. P. M. Tak, Aartjan T.F. Beekman, Peter N. van Harten, M. Hopman-Rock, Ingrid J.M. Hendriksen · 2017 · Psychiatry Research
  64. Nutritional psychiatry in the treatment of psychotic disorders: Current hypotheses and research challenges
    Scott B. Teasdale, Sabrina Mörkl, Annabel Sandra Mueller‐Stierlin · 2020 · Brain Behavior & Immunity - Health
  65. The prevalence, risk factors and clinical correlates of obesity in Chinese patients with schizophrenia
    Qiongzhen Li, Xiangdong Du, Yingyang Zhang, Guangzhong Yin, Guangya Zhang, Consuelo Walss‐Bass, João Quevedo, Jair C. Soares, Haishen Xia, Xiaosi Li et al. · 2016 · Psychiatry Research
  66. Effects of high intensity interval training among overweight individuals with psychotic disorders: A randomized controlled trial
    Ahmed Jérôme Romain, Cédine Fankam, Antony D. Karelis, Elainte Letendre, Gladys Mikolajczak, Émmanuel Stip, Amal Abdel‐Baki · 2018 · Schizophrenia Research
  67. Up-to-date expert opinion on the safety of recently developed antipsychotics
    Laura Orsolini, Domenico De Berardis, Umberto Volpe · 2020 · Expert Opinion on Drug Safety
  68. Automated diagnosis of schizophrenia using EEG microstates and Deep Convolutional Neural Network
    Eric Lillo, Marco Mora, Boris Andrés Lucero · 2022 · Expert Systems with Applications
  69. Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges
    P. Haddad, C. Correll · 2023 · Expert Opinion on Pharmacotherapy
  70. Dynamic Changes of the Mitochondria in Psychiatric Illnesses: New Mechanistic Insights From Human Neuronal Models
    Rupali Srivastava, Travis E. Faust, Adriana Ramos, Koko Ishizuka, Akira Sawa · 2018 · Biological Psychiatry
  71. Physical Health Care for People with Severe Mental Illness: the Attitudes, Practices, and Training Needs of Nurses in Three Asian Countries
    Daniel Thomas Bressington, Ashish Badnapurkar, Sachiko Înoue, Hin Yeung, Wai Tong Chien, Deborah Nelson, Richard John Gray · 2018 · International Journal of Environmental Research and Public Health
  72. Metabolic and Microbiota Measures as Peripheral Biomarkers in Major Depressive Disorder
    Rachael G. Horne, Jane Allyson Foster · 2018 · Frontiers in Psychiatry
  73. Hippocampal volume and vasculature before and after exercise in treatment-resistant schizophrenia
    Melissa L. Woodward, Kristina M. Gicas, Darren E. R. Warburton, Randall F. White, Alexander Rauscher, Olga Leonova, Wayne Su, G.N. Smith, Allen E. Thornton, Alexandra Talia Vertinsky et al. · 2018 · Schizophrenia Research
  74. Sedentary behavior and depression among community-dwelling adults aged ≥50 years: Results from the irish longitudinal study on Ageing
    Davy Vancampfort, Mats Å. Hallgren, Felipe Barreto Schuch, Brendon Stubbs, Lee Smith, Simon Rosenbaum, Joseph Firth, Tine Van Damme, Ai Koyanagi · 2019 · Journal of Affective Disorders
  75. Relationship Between Objectively Measured Sedentary Behavior and Cognitive Performance in Patients With Schizophrenia Vs Controls
    Brendon Stubbs, Po‐Wen Ku, Ming-Shun Chung, Li‐Jung Chen · 2016 · Schizophrenia Bulletin
  76. Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia
    Anastasiia S. Boiko, Irina A. Mednova, Elena G. Kornetova, Arkadiy V. Semke, Nikolay A. Bokhan, ANTON J. M. LOONEN, Svetlana А. Ivanova · 2019 · Heliyon
  77. Affective disorders impact prevalence of Flavonifractor and abundance of Christensenellaceae in gut microbiota
    Klara Coello, Tue H. Hansen, Nikolaj Sørensen, Ninja Meinhard Ottesen, Kamilla Woznica Miskowiak, Oluf Borbye Pedersen, Lars Vedel Kessing, Maj Vinberg · 2021 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  78. Childhood trauma, the stress response and metabolic syndrome: A focus on DNA methylation
    Jacqueline Samantha Womersley, Jani Nöthling, Sylvanus Toikumo, Stefanie Malan‐Müller, Leigh L. van den Heuvel, Nathaniel W. McGregor, Soraya Seedat, Sian M. J. Hemmings · 2021 · European Journal of Neuroscience
  79. EPA guidance on lifestyle interventions for adults with severe mental illness: A meta-review of the evidence
    Isabel Maurus, Sarah A. Wagner, Johanna Spaeth, Anastasia Vogel, Susanne Muenz, Valentina Seitz, Peter von Philipsborn, Marco Solmi, Joseph Firth, Brendon Stubbs et al. · 2024 · European Psychiatry
  80. Mania-related effects on structural brain changes in bipolar disorder – a narrative review of the evidence
    Christoph Abé, Benny Liberg, Anna Luisa Klahn, Predrag Petrović, Mikael Landén · 2023 · Molecular Psychiatry
  81. Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis
    Nicholas Fabiano, Stanley Wong, Carl Zhou, Christoph Ulrich Correll, Mikkel Højlund, Marco Solmi · 2024 · European Neuropsychopharmacology
  82. Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?
    Rodrigo Barbachan Mansur, Yena L. Lee, Mehala Subramaniapillai, Elisa Macedo Brietzke, Roger S. McIntyre · 2018 · Neuropharmacology
  83. Cardiovascular risk remains high in schizophrenia with modest improvements in bipolar disorder during past decade
    Linn Nilsen Rødevand, Nils Eiel Steen, Torbjørn Elvsåshagen, Daniel S. Quintana, Elina Johanna Reponen, Ragni Helene Mørch, Synve Hoffart Lunding, Trude Seselie Jahr Vedal, Ingrid Dieset, Ingrid S. Melle et al. · 2019 · Acta Psychiatrica Scandinavica
  84. Exercise Intervention in Treatment of Neuropsychological Diseases: A Review
    Zichao Chen, Wencen Lan, Guifen Yang, Yan Li, Ji Xiang, Lan Chen, Yan Ni Zhou, Shanshan Li · 2020 · Frontiers in Psychology
  85. Metabolic Syndrome Impairs Executive Function in Bipolar Disorder
    Nina Dalkner, Susanne Bengesser, Armin Birner, Frederike T. Fellendorf, Eva Fleischmann, Katja Großschädl, Melanie Lenger, Alexander Maget, Martina Platzer, Robert Queissner et al. · 2021 · Frontiers in Neuroscience
  86. Physiotherapy and Mental Health
    Michel Probst · 2017 · InTech eBooks
  87. Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT)
    on behalf of the IMPaCT Team, Fiona Gaughran, Daniel R. Stahl, Khalida Ismail, Kathryn Greenwood, Zerrin Atakan, Poonam Gardner-Sood, Brendon Stubbs, David Hopkins, Anita K. Patel et al. · 2017 · BMC Psychiatry
  88. Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients
    Julia Lappin, Marlene Wijaya, Andrew Watkins, Rachel Morell, Scott B. Teasdale, Oscar Lederman, Simon Rosenbaum, Stephanie Dick, Philip B. Ward, Jackie Curtis · 2018 · Schizophrenia Research
  89. Exercise and Schizophrenia
    Javier Bueno‐Antequera, Diego Munguía‐Izquierdo · 2020 · Advances in experimental medicine and biology
  90. Metabolic syndrome and psychiatric disorders: a population-based study
    Moreira, Fernanda Pedrotti, Jansen, Karen, Cardoso, Taiane de A., Mondin, Thaíse C., Magalhães, Pedro V., Kapczinski, Flavio, Souza, Luciano D.M., da Silva, Ricardo A., Oses, Jean Pierre, Wiener, Carolina D. · 2019 · Brazilian Journal of Psychiatry
  91. Effect of high-intensity interval training on cardiorespiratory fitness, physical activity and body composition in people with schizophrenia: a randomized controlled trial
    Eivind Andersen, Gry Bang-Kittilsen, Therese Torgersen Bigseth, Jens Egeland, Tom Langerud Holmen, Egil Wilhelm Martinsen, Trine Stensrud, John Abel Engh · 2020 · BMC Psychiatry
  92. Factors and their weight in reducing life expectancy in schizophrenia
    Christoph Ulrich Correll, István Bitter, Fabian J. Hoti, Juha Mehtälä, Annette Wooller, Katalin Pungor, Jari Tiihonen · 2022 · Schizophrenia Research
  93. Mortality, morbidity and medical resources utilization of patients with schizophrenia: A case-control community-based study
    Shay Gur, Shira Weizman, Brendon Stubbs, Andre Matalon, Joseph Meyerovitch, Haggai Hermesh, Amir Krivoy · 2017 · Psychiatry Research
  94. Sprint interval training (SIT) substantially reduces depressive symptoms in major depressive disorder (MDD): A randomized controlled trial
    Alice Minghetti, Oliver Faude, Henner Hanssen, Lukas Zahner, Markus Gerber, Lars Donath · 2018 · Psychiatry Research
  95. Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children
    Francisco Madrid-Gambín, Melanie Föcking, Sophie Sabherwal, Meike Heurich, Jane A. English, Aoife O’Gorman, Tommi Suvitaival, Linda L. Ahonen, Mary D Cannon, Glyn Lewis et al. · 2019 · Biological Psychiatry
  96. Loneliness in psychotic illness and its association with cardiometabolic disorders
    Johanna Claire Badcock, Andrew James Mackinnon, Anna J Waterreus, Gerald Francis Watts, David Jonathan Castle, John Joseph McGrath, Vera Anne Morgan · 2018 · Schizophrenia Research
  97. How to treat mania
    Isabella Pacchiarotti, Gerard Anmella, Lluc Colomer, Eduard Vieta · 2020 · Acta Psychiatrica Scandinavica
  98. Older Age Bipolar Disorder
    Annemiek Dols, Aartjan T.F. Beekman · 2017 · Psychiatric Clinics of North America
  99. Cardiorespiratory fitness levels and moderators in people with HIV: A systematic review and meta-analysis
    Davy Vancampfort, James Mugisha, Simon Rosenbaum, Joseph Firth, Marc De Hert, Michel Probst, Brendon Stubbs · 2016 · Preventive Medicine
  100. Prevalence of metabolic syndrome and its components among patients with various psychiatric diagnoses and treatments: A cross-sectional study
    Fahad Dakheel Alosaimi, Mohammed F. Abalhassan, Bandar Alhaddad, Nasser M. Alzain, Ebtihaj Omar Fallata, Abdulhadi A. Alhabbad, Mohammed Z. Alassiry · 2016 · General Hospital Psychiatry